Quotes from physicians

Carol Ann Ryser, M.D.

"I believe that people with high risk in their family of cancer, or people over 45 or 50 should definitely take the test. People over 45 or 50 should be screened with the AMAS® Test in the same way people receive routine mammographies and other kinds of tests including the PSA. I think the AMAS® Test should be included.

In my practice I’ve also used this test effectively in patients with clinical symptoms that are not clear: i.e . vague clinical symptoms. To give you a short example a 35 year old woman was having pelvic pain and she had just delivered a baby. She had seen several physicians. They diagnosed here with irritable bowel but they didn’t know what was going on, so she came to see me. I did the AMAS® because the pain was getting more severe and more intense for her and no one could see anything. The AMAS® TEST was positive. So I called one of my Oncology/Gyn friends and said you have got to look over this lady very carefully. There is something going on in her pelvis. Amazingly they found a small malignant tumor at the junction of the cervix and the vaginal wall –a very small little knot. They took it out. The pain went away. Her AMAS® came back to normal after three or four months and that was two or three years ago and she’s been healthy ever since. It was a malignant tumor. It is phenomenal. And of course her family is grateful, three children, and her husband. Most people who come in will have some area in their body they are complaining about. She had focused discomfort and pain- clinical symptoms. When you zero in on that area first and then you expand to other general evaluations, you usually are able to find the source of the problem. This a classic example where a young lady would have probably developed severe cancer over the next two years. It was exciting to find the cancer early.

I rely on colleagues in the relevant areas of specialty to explore the lung, the breast. They do their part of the evaluation. I use the AMAS® Test with my patients as part of the total review which includes family history, personal history, physicians review. I use all of the diagnostic tests together.”

Carol Ann Ryser, M.D.
Kansas City, MO

Margaret Rank, M.D.

"The AMAS test is a powerful diagnostic and prognostic tool when used properly. Measuring the levels of antibodies to Malignin, it can be used to diagnose sub-clinical cancer. That is, it can detect very small tumors before they become evident by usual diagnostic tests and physical exam. Small cancers can often be treated for cure with either conventional means or natural means. This is truly one of the weapons against cancer that is grossly underutilized.

Use of the AMAS can prevent unnecessary procedures or prompt further investigation. For instance, statistics show that up to nine of 10 biopsies done because of an "abnormal" mammogram, are done for non-cancerous lesions. Also, many of the pathology reports of breast biopsies read as cancerous actually represent benign (non-cancerous) conditions. If the AMAS were used in these cases, many unnecessary, anxiety provoking surgical procedures could be avoided. Additionally, misdiagnoses of breast cancer that often lead to chemotherapy and radiation treatment, could be avoided in many cases. The mammogram is far too sensitive (it detects "disease" frequently when there is none), very non-specific (it can't always separate benign from malignant disease) and can deal a potentially cancer-causing dose of radiation. I have replaced this by breast MRI and/or the AMAS test. I have helped many of my patients avoid unnecessary surgery or biopsies with judicious use of this test.

The AMAS, in conjunction with other clinical studies including assessment of the immune system, can help follow the progress of treatment or the need for intensification of therapy when dealing with a known cancer. It also assists with prognosis, detection of tumor progression or regression, and efficacy of a particular treatment protocol.

To patients, I suggest strongly that they find a competent clinician familiar with the AMAS test and its interpretation to assess their individual needs and guide them in their decision-making.”

Margaret Rank, M.D.
Melbourne, FL